Related references
Note: Only part of the references are listed.Mechanism of caspase-2 activation upon DNA damage
V. I. Aksenova et al.
DOKLADY BIOCHEMISTRY AND BIOPHYSICS (2016)
Emerging Strategies for Developing Next-Generation Protein Therapeutics for Cancer Treatment
James R. Kintzing et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2016)
A highly stable and biocompatible optical bioimaging nanoprobe based on carbon nanospheres
Xiaolong Liu et al.
RSC ADVANCES (2016)
Targeted delivery of cisplatin by LHRH-peptide conjugated dextran nanoparticles suppresses breast cancer growth and metastasis
Mingqiang Li et al.
ACTA BIOMATERIALIA (2015)
Silencing β3 Integrin by Targeted ECO/siRNA Nanoparticles Inhibits EMT and Metastasis of Triple-Negative Breast Cancer
Jenny G. Parvani et al.
CANCER RESEARCH (2015)
Dual AO/EB Staining to Detect Apoptosis in Osteosarcoma Cells Compared with Flow Cytometry
Kuan Liu et al.
MEDICAL SCIENCE MONITOR BASIC RESEARCH (2015)
Biocompatible, Uniform, and Redispersible Mesoporous Silica Nanoparticles for Cancer- Targeted Drug Delivery In Vivo
Quan Zhang et al.
ADVANCED FUNCTIONAL MATERIALS (2014)
Regulated Cell Death: Signaling and Mechanisms
Avi Ashkenazi et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 30 (2014)
Treatment of metastatic breast cancer by combination of chemotherapy and photothermal ablation using doxorubicin-loaded DNA wrapped gold nanorods
Dangge Wang et al.
BIOMATERIALS (2014)
Dual drugs (microRNA-34a and paclitaxel)-loaded functional solid lipid nanoparticles for synergistic cancer cell suppression
Sanjun Shi et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Drug-excipient compatibility screening-Role of thermoanalytical and spectroscopic techniques
Renu Chadha et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2014)
PEGylated Micelle Nanoparticles Encapsulating a Non-Fluorescent Near-Infrared Organic Dye as a Safe and Highly-Effective Photothermal Agent for In Vivo Cancer Therapy
Liang Cheng et al.
ADVANCED FUNCTIONAL MATERIALS (2013)
A mesoporous silica nanoparticle - PEI - Fusogenic peptide system for siRNA delivery in cancer therapy
Xu Li et al.
BIOMATERIALS (2013)
Caspase-9, caspase-3 and caspase-7 have distinct roles during intrinsic apoptosis
Matthew Brentnall et al.
BMC CELL BIOLOGY (2013)
Preparation of amphiphilic hollow carbon nanosphere loaded insulin for oral delivery
Moorthy Ganeshkumar et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2013)
The formulation and delivery of curcumin with solid lipid nanoparticles for the treatment of on non-small cell lung cancer both in vitro and in vivo
Ping Wang et al.
MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2013)
Caspase Functions in Cell Death and Disease
David R. McIlwain et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
SYNTHESIS OF STRUCTURALLY NOVEL CARBON MICRO/NANOSPHERES BY LOW TEMPERATURE-HYDROTHERMAL PROCESS
G. Krishnamurthy et al.
JOURNAL OF THE CHILEAN CHEMICAL SOCIETY (2013)
PET Imaging of Estrogen Receptors as a Diagnostic Tool for Breast Cancer Patients Presenting with a Clinical Dilemma
Michel van Kruchten et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Nanoparticles in targeted cancer therapy: mesoporous silica nanoparticles entering preclinical development stage
Jessica M. Rosenholm et al.
NANOMEDICINE (2012)
Impact of Excipient Interactions on Solid Dosage Form Stability
Ajit S. Narang et al.
PHARMACEUTICAL RESEARCH (2012)
pH-Controlled Delivery of Doxorubicin to Cancer Cells, Based on Small Mesoporous Carbon Nanospheres
Jie Zhu et al.
SMALL (2012)
Hollow Carbon Nanospheres with Superior Rate Capability for Sodium-Based Batteries
Kun Tang et al.
ADVANCED ENERGY MATERIALS (2012)
Growth of carbon nanospheres through a building block assembly method at 300 degrees C
Xin Xu et al.
CARBON (2011)
Antibody-enzyme fusion proteins for cancer therapy
Carima Andrady et al.
IMMUNOTHERAPY (2011)
Coordinated regulation of p53 apoptotic targets BAX and PUMA by SMAR1 through an identical MAR element
Surajit Sinha et al.
EMBO JOURNAL (2010)
Bacteria in cancer therapy: a novel experimental strategy
S. Patyar et al.
JOURNAL OF BIOMEDICAL SCIENCE (2010)
Synthetic pH-Responsive Polymers for Protein Transduction
William B. Liechty et al.
ADVANCED MATERIALS (2009)
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
Maggie C. U. Cheang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
A Novel Route for Preparation of Hollow Carbon Nanospheres Without Introducing Template
Minmin Li et al.
NANOSCALE RESEARCH LETTERS (2009)
Cancer Associated Fibroblasts Promote Tumor Growth and Metastasis by Modulating the Tumor Immune Microenvironment in a 4T1 Murine Breast Cancer Model
Debbie Liao et al.
PLOS ONE (2009)
Gold nanoparticle-colloidal carbon nanosphere hybrid material: Preparation, characterization, and application for an amplified electrochemical immunoassay
Rongjing Cui et al.
ADVANCED FUNCTIONAL MATERIALS (2008)
Intrinsically Fluorescent Carbon Nanospheres as a Nuclear Targeting Vector: Delivery of Membrane-Impermeable Molecule to Modulate Gene Expression In Vivo
B. Ruthrotha Selvi et al.
NANO LETTERS (2008)
Protein therapeutics: A summary and pharmacological classification
Benjamin Leader et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Immunogenicity of protein therapeutics
Anne S. De Groot et al.
TRENDS IN IMMUNOLOGY (2007)
18F-FDG PET in detecting primary breast cancer
Rakesh Kumar et al.
JOURNAL OF NUCLEAR MEDICINE (2007)
Morphological study on apoptosis Hela cells induced by soyasaponins
Jun-Xia Xiao et al.
TOXICOLOGY IN VITRO (2007)
SMAR1-derived p44 peptide retains its tumor suppressor function through modulation of p53
Archana Jalota-Badhwar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Effect of intratumoral injection on the biodistribution and the therapeutic potential of HPMA copolymer-based drug delivery systems
Twan Lammers et al.
NEOPLASIA (2006)
Lymphatic or hematogenous dissemination: How does a metastatic tumor cell decide?
Sunny Y. Wong et al.
CELL CYCLE (2006)
Proliferation marker Ki-67 in early breast cancer
A Urruticoechea et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Tumor suppressor SMAR1 mediates cyclin D1 repression by recruitment of the SIN3/histone deacetylase 1 complex
S Rampalli et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Caspase-2 function in response to DNA damage
B Zhivotovsky et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Tumor suppressor SMAR1 activates and stabilizes p53 through its arginine-serine-rich motif (Publication with Expression of Concern. See vol. 294, pg. 17708, 2019) (Withdrawn Publication. See vol. 295, pg. 3390, 2020)
A Jalota et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Treatment of terminal peritoneal carcinomatosis by a transducible p53-activating peptide
EL Snyder et al.
PLOS BIOLOGY (2004)
Colloidal carbon spheres and their core/shell structures with noble-metal nanoparticles
XM Sun et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2004)
Direct interaction with and activation of p53 by SMAR1 retards cell-cycle progression at G2/M phase and delays tumor growth in mice
R Kaul et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
FDG uptake in breast cancer:: correlation with biological and clinical prognostic parameters
A Buck et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2002)
Share Paper
